HOMEVULNERABILITIESCVE-2020-11580
CRITICAL

CVE-2020-11580

CWE-295Published: April 6, 2020· Updated: Jun 17, 2026

9.1
CVSS v3.1

Official Description

An issue was discovered in Pulse Secure Pulse Connect Secure (PCS) through 2020-04-06. The applet in tncc.jar, executed on macOS, Linux, and Solaris clients when a Host Checker policy is enforced, accepts an arbitrary SSL certificate.

NVD Source

Technical Analysis

CVE-2020-11580 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.

The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.

A successful exploit results in complete confidentiality breach (data exposure), full integrity compromise (data manipulation), with a CVSS base score of 9.1.

CVSS v3.1 Vector Breakdown

Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityHigh
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N

Affected Vendors & Products

Apple1 product(s)
macos
Linux1 product(s)
linux kernel
Oracle1 product(s)
solaris
pulsesecure2 product(s)
pulse connect securepulse policy secure
Source: NVD CPE · 5 total CPE entries

Exploit & PoC Resources

NO KNOWN EXPLOITNo public exploit confirmed at this time
External links open in a new tab. Always verify in a controlled environment before use.

Official Patches & Advisories

All References (4)

Quick Facts

CVE IDCVE-2020-11580
CVSS Score9.1 / 10
SeverityCRITICAL
WeaknessCWE-295
CISA KEVNo
Affected4 vendor(s)
PublishedApr 6, 2020

Related CVEs (CWE-295)

Recommended Actions

  • Apply vendor patches immediately
  • Monitor CVE-2020-11580 in threat intel feeds
  • Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.